Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin Pre-treatment for Exercise in MS
NCT03051646Phase 1Completed
- Sponsor
- Columbia University
- Start
- Jan 2017
- Primary completion
- May 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of aspirin in relapsing-remitting multiple sclerosis (RRMS) (2 arms), sponsored by Columbia University. Primary endpoint: Change in Time to Exhaustion at Day 14. Started Jan 2017; status: completed.
02
Drugs
aspirin
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT03051646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03051646.